Editorial Commentary: Arthroscopic Treatment Should No Longer Be Offered to People With Subacromial Impingement.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 35940744.
- Also identified by DOI 10.1016/j.arthro.2022.03.017.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Arthroscopic treatment should no longer be offered to people with subacromial impingement. In many people, subacromial impingement (or subacromial pain syndrome) is self-limiting and may not require any specific treatment. This is evident by the fact that almost 50% of people with new-onset shoulder pain consult their primary care doctor only once. The best-available evidence from randomized controlled trials indicates that glucocorticoid injection provides rapid, modest, short-term pain relief. Exercise therapy has also been found to provide no added benefit over glucocorticoid injection. Subacromial decompression (bursectomy and acromioplasty) for subacromial pain syndrome provides no important benefit on pain, function, or health-related quality of life. Acromioplasty does not improve the outcomes of rotator cuff repair.
Medical subject headings
- Quality of Life
- Shoulder Impingement Syndrome
Anatomy
- shoulder